Afro5h
Neurologist speaks on fighting Alzheimer’s Disease with diet and exercise
Discover how exercise, a healthy diet, and socialization can help combat Alzheimer's disease. Learn more about the importance ...
NBC 10 Philadelphia on MSN2h
Pennsylvania woman becomes 1st to receive promising new Alzheimer's treatment
A Pennsylvania woman is one of the first patients in the country to receive a new FDA-approved treatment for early ...
Alzheimer's treatment that uses Benfotiamine will be tested in large clinical trial
Researcher Gary Gibson talks at Burke in White Plains about a trial on a new treatment for Alzheimer’s that uses Benfotiamine ...
McKnight's Long-Term Care News3h
Journalists question safety and effectiveness of new Alzheimer’s drug
A report published Wednesday in The BMJ questioned the safety and effectiveness of the Alzheimer’s disease drug Kisunla ...
Barbara Corcoran Talks About Her Mother’s Alzheimer’s Diagnosis: 'It's Grieving in Slow Motion' (Exclusive)
The 'Shark Tank' star and real-estate icon shares how she and her 9 siblings became caregivers when their mother, Florence, ...
Questions over safety and effectiveness of new Alzheimer's drug
The safety and effectiveness of donanemab—an Alzheimer's drug recently approved by the US Food & Drug Administration (FDA)—is ...
Journal Record7h
OMRF receives $3.7M NIH grant for Alzheimer’s research
The National Institutes of Health awarded a five-year, $3.7 million grant to the Oklahoma Medical Research Foundation (OMRF) ...
Psychology Today2d
What Does Obesity Have to Do With Alzheimer’s Disease?
Leptin, a hormone that helps with weight control, also plays a role in normal cognition. Leptin resistance occurs when the ...
Opinion: Help Connecticut residents navigate through Alzheimer’s
The Connecticut State Department of Health forecasts the number of Connecticut residents living with Alzheimer’s to grow to ...
studyfinds12h
Alzheimer’s drug breakthrough or breakdown? Investigation exposes red flags in FDA approval of donanemab
A startling investigation has revealed a troubling story behind donanemab's approval -- one of questionable data, potential ...